臨床試験を検索：2nd line ART ( Zidovudine 300mg BID Lamivudine 150mg BID or Tenofovir DF 300mg QD Lamividine 300
合計7件
-
University of WashingtonNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp & Dohme LLC; Janssen... と他の協力者終了しました
-
Immunomolecular Therapeutics, Inc.WCCT Global完了
-
Boehringer Ingelheim完了
-
University of Colorado, DenverNational Institute of Allergy and Infectious Diseases (NIAID); University of Hawaii完了
-
Rhonda BrandNational Institute of Allergy and Infectious Diseases (NIAID)完了